表紙
市場調査レポート

ポイントオブケア脂質検査 (POC脂質検査) の世界市場:2015〜2019年

Global POC Lipid Testing Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 325007
出版日 ページ情報 英文 74 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
ポイントオブケア脂質検査 (POC脂質検査) の世界市場:2015〜2019年 Global POC Lipid Testing Market 2015-2019
出版日: 2015年02月25日 ページ情報: 英文 74 Pages
概要

POC (Point of Care:ポイントオブケア) 脂質検査では、血液中の脂質レベル (総コレステロール、LDL (低密度リポタンパク質)、HDL (高密度リポタンパク質)、トリグリセリドのレベル) を測定します。分析結果がすぐに得られるので、その場で患者に治療・薬剤を提供できます。肥満症・糖尿病・心臓病などの生活慣習病の発症数が増加するのに対応して、世界各国でPOC脂質検査ができる体制を整備する必要が出てきました。POC脂質検査製品はコスト効率的で使いやすく、また診断中のミスの発生を押さえるために標準化されています。世界のPOC脂質検査市場は、2014〜2019年にかけて、6.04%の年平均成長率 (CAGR) で成長する見通しです。

当レポートでは、全世界のPOC脂質検査 (ポイントオブケア脂質検査) 市場について分析し、市場の概要や構造、市場規模の動向 (今後5年間の予測値)、地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・考察しております。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 概要

  • 世界の総人口
  • 肥満症の発症数
  • 肥満症患者の対人口比率

第7章 市場情勢

  • 市場概要
  • 市場規模と予測
  • 米国のPOC脂質検査市場
  • 欧州のPOC脂質検査市場
  • ファイブフォース分析

第8章 用途別の市場区分

第9章 地域区分

  • 南北アメリカのPOC脂質検査市場
  • 欧州・中東・アフリカ (EMEA) 地域のPOC脂質検査市場
  • アジア太平洋地域のPOC脂質検査市場

第10章 購入基準

第11章 市場成長促進要因

第12章 成長促進要因とその影響

第13章 市場の課題

第14章 成長促進要因と課題の影響

第15章 市場動向

第16章 動向とその影響

第17章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • 企業合併・買収 (M&A)
  • ベンダー分析
    • 一般的な製品ポートフォリオ
  • その他の有力ベンダー

第18章 主要ベンダーの分析

  • Abbott Laboratories
    • 主要データ
    • 事業概要
    • 部門別の市場収益額
    • 部門別の市場収益額 (過去2年間分)
    • 地域別の市場収益額
    • 事業戦略
    • 主要情報
    • SWOT分析
  • Alere
  • F. Hoffmann-La Roche
  • PTS Diagnostics

第19章 関連レポート

図表一覧

目次
Product Code: IRTNTR5375

About POC Lipid Testing

POC lipid testing helps determine blood lipid levels, which includes the measurement of total cholesterol, LDL, HDL, and triglyceride levels. The results are obtained quickly and, therefore, helps provide rapid treatments and medication to a patient. The increasing incidence of lifestyle diseases such as obesity, diabetes, and cardiac disease is responsible for establishing POC lipid testing worldwide; it is cost-effective and user-friendly. POC lipid testing products are standardized to minimize errors during testing.

TechNavio's analysts forecast the Global POC Lipid Testing market to grow at a CAGR of 6.04 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global POC Lipid Testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of POC lipid testing products used for various applications including:

  • Total cholesterol testing
  • HDL testing
  • LDL testing
  • Triglycerides testing

TechNavio's report, the Global POC Lipid Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global POC Lipid Testing market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Alere
  • F. Hoffmann-La Roche
  • PTS

Other Prominent Vendors

  • A. Menarini Diagnostics
  • Abaxis
  • Accutech
  • Acon
  • Bayer Healthcare
  • BD
  • bioMerieux
  • Bio-Rad Laboratories
  • Corgenix
  • Danaher
  • Eurotrol
  • General Life Biotechnology
  • Helena Laboratories
  • Nova Biomedical
  • OraSure Technologies
  • Quidel
  • Randox Laboratories
  • Sekisui Diagnostics
  • Siemens Healthcare
  • Sysmex
  • Trinity Biotech

Market Driver

  • Increase in Obesity and Cardiac Disorders
  • For a full, detailed list, view our report

Market Challenge

  • Threat of Laboratory Lipid Testing
  • For a full, detailed list, view our report

Market Trend

  • Increased Adoption of POC Lipid Testing
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Overview

  • 06.1. World Population
    • 06.1.1. Forecast of World Population
  • 06.2. Incidence of Obesity
    • 06.2.1. Forecast of World Population
  • 06.3. Percentage of Population Suffering from Obesity

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. POC Lipid Testing Market in US
    • 07.3.1. Market Size and Forecast
  • 07.4. POC Lipid Testing Market in Europe
    • 07.4.1. Market Size and Forecast
  • 07.5. Five Forces Analysis

08. Market Segmentation by Application

09. Geographical Segmentation

  • 09.1. POC Lipid Testing Market in Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. POC Lipid Testing Market in EMEA Region
    • 09.2.1. Market Size and Forecast
  • 09.3. POC Lipid Testing Market in APAC Region
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Vendor Analysis 2014
    • 17.2.1. Popular Products Portfolio
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Abbott Laboratories
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation by Revenue
    • 18.1.4. Business Segmentation by Revenue 2011 and 2012
    • 18.1.5. Geographical Segmentation by Revenue
    • 18.1.6. Business Strategy
    • 18.1.7. Key Information
    • 18.1.8. SWOT Analysis
  • 18.2. Alere
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation by Revenue 2013
    • 18.2.4. Business Segmentation by Revenue 2012 and 2013
    • 18.2.5. Geographical Segmentation by Revenue 2013
    • 18.2.6. Business Strategy
    • 18.2.7. Recent Developments
    • 18.2.8. SWOT Analysis
  • 18.3. F. Hoffmann-La Roche
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation
    • 18.3.4. Geographical Segmentation by Revenue 2013
    • 18.3.5. Business Strategy
    • 18.3.6. Key Information
    • 18.3.7. SWOT Analysis
  • 18.4. PTS Diagnostics
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Recent Developments
    • 18.4.4. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: World Population 2014-2019 (million)
  • Exhibit 3: Incidence of Obesity 2014-2019 (million)
  • Exhibit 4: Percentage of World Population Suffering from Obesity 2014-2019
  • Exhibit 5: Global POC Lipid Testing Market 2014-2019 (US$ million)
  • Exhibit 6: POC Lipid Testing Market in US 2014-2019 (US$ million)
  • Exhibit 7: POC Lipid Testing Market in Europe 2014-2019 (US$ million)
  • Exhibit 8: Segmentation of Global POC Lipid Testing Market by Application
  • Exhibit 9: Geographical Segmentation of Global POC Lipid Testing Market 2014 and 2019
  • Exhibit 10: POC Lipid Testing Market in Americas 2014-2019 (US$ million)
  • Exhibit 11: POC Lipid Testing Market in EMEA Region 2014-2019 (US$ million)
  • Exhibit 12: POC Lipid Testing Market in APAC Region 2014-2019 (US$ million)
  • Exhibit 13: Geographical Segmentation of Global POC Lipid Testing Market 2014-2019 (US$ million)
  • Exhibit 14: Geographical Segmentation of Global POC Lipid Testing Market 2014-2019
  • Exhibit 15: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 16: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 17: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 18: Global POC Lipid Testing Market: Business Segmentation by Revenue 2013
  • Exhibit 19: Global POC Lipid Testing Market: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 20: Global POC Lipid Testing Market: Geographical Segmentation by Revenue 2013
  • Exhibit 21: F. Hoffmann-La Roche: Business Segmentation 2013
  • Exhibit 22: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 23: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
  • Exhibit 24: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)
Back to Top